Federal Circuit affirms PTAB’s Baxter ruling
11-03-2021
JHVEphoto / Shutterstock.com
American healthcare multinational Baxter has accused B.Braun of patent infringement and fraudulent misrepresentation in an on-going dispute over products used to treat acute kidney injury.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Baxter, B.Braun, patent infringement, kidney treatment, fraud, misrepresentation, acute kidney injury, blood treatment, medical devices
